I just re-read the 4C, and revenue growth for 20/21 will be approximately 15% over the prior year - with this obviously being impacted negatively by COVID.
And new sales were far higher than revenue at $25.6m for 20/21 - despite the slower Q4 sales total of $4.4m.
Based on the comments in this quarterly, particularly the comments about new contracted revenue that is already landing in this 21/22 FY, I would be very surprised if M7T's revenue for 21/22 wasn't upwards of $25m (30% + increase on this FY).
With around $18.4m in the bank, a second consecutive cash flow positive year , and hospitals more focussed on making decision around "improvements" - there is definitely a lot to like here
Ann: Q4 Quarterly Activities Report, page-36
Add M7T (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $86.84M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $141.6K | 388.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 67251 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 7500 | 1 |
View Market Depth
| Last trade - 15.58pm 19/11/2024 (20 minute delay) ? |
| M7T (ASX) Chart |